We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

49 hedge funds and large institutions have $44.8M invested in Filana Therapeutics in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

20% more capital invested

Capital invested by funds: $37.2M → $44.8M (+$7.58M)

0% more funds holding

Funds holding: 49 → 49 (0)

0% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 14

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
14
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$2.41M
2
BI
BVF Inc
California
+$1.75M
3
GIM
Granahan Investment Management
Massachusetts
+$834K
4
Renaissance Technologies
Renaissance Technologies
New York
+$144K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$44.5K

Top Sellers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
-$1.29M
2
Morgan Stanley
Morgan Stanley
New York
-$175K
3
Goldman Sachs
Goldman Sachs
New York
-$163K
4
Millennium Management
Millennium Management
New York
-$140K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$84.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
26
Virtu KCG Holdings
New York
$63K +$1.22K +92 +2%
ACM
27
Avalon Capital Management
California
$57K – – –
Goldman Sachs
28
Goldman Sachs
New York
$51K -$163K -12,317 -75%
ARTA
29
A.R.T. Advisors
New York
$50K +$14.2K +1,071 +35%
Bank of America
30
Bank of America
North Carolina
$49K -$56.8K -4,294 -52%
Millennium Management
31
Millennium Management
New York
$48K -$140K -10,573 -73%
Morgan Stanley
32
Morgan Stanley
New York
$39K -$175K -13,238 -80%
Charles Schwab
33
Charles Schwab
California
$33K – – –
BIP
34
Brandes Investment Partners
California
$32K -$1.5K -113 -4%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$21K -$84.3K -6,373 -79%
TC
36
TFS Capital
Pennsylvania
$20K -$4.3K -325 -17%
PPA
37
Parametric Portfolio Associates
Washington
$18K – – –
Wells Fargo
38
Wells Fargo
California
$18K +$5.49K +415 +41%
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$18K +$18.3K +1,386 +3,223%
BA
40
BlackRock Advisors
Delaware
$15K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$14K +$15.7K +1,185 New
BIM
42
BlackRock Investment Management
Delaware
$12K +$212 +16 +2%
Deutsche Bank
43
Deutsche Bank
Germany
$8K +$8.67K +655 New
UBS Group
44
UBS Group
Switzerland
$7K +$4.91K +371 +288%
Citigroup
45
Citigroup
New York
$2K -$28.4K -2,143 -91%
MFS
46
MSI Financial Services
Massachusetts
$1K -$754 -57 -33%
TCOV
47
Trust Company of Vermont
Vermont
$1K – – –
Citadel Advisors
48
Citadel Advisors
Florida
– -$17K -1,298 Closed
PNC Financial Services Group
49
PNC Financial Services Group
Pennsylvania
– -$1K -81 Closed
Simplex Trading
50
Simplex Trading
Illinois
– +$873 +66 New
1
2

FLNA Hedge Fund Activity: Q4 2015 in Review

49 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2015, worth a combined $44.8M — up 20% from $37.2M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new FLNA positions and 3 closed out — a net gain of 1 holder — while 14 added to existing stakes and 14 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $2.41M. The largest seller was J. Goldman & Co, cutting an estimated $1.29M.

  • 49 institutional investors held Filana Therapeutics (FLNA) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $44.8M of Filana Therapeutics stock for Q4 2015, up 20% quarter-over-quarter.
  • 4 funds opened new Filana Therapeutics positions in Q4 2015 and 3 closed out, a net change of +1 holder.
  • The largest Filana Therapeutics buyer in Q4 2015 was Nantahala Capital Management, an estimated $2.41M added.
  • The largest Filana Therapeutics seller in Q4 2015 was J. Goldman & Co, an estimated $1.29M sold.

Based on aggregated 13F filings for Q4 2015.